A Safety Study of LY3462817 in Healthy Participants

NCT03715192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: LY3462817 IV
BIOLOGICAL: LY3462817 SC
DRUG: Placebo

Sponsor

Eli Lilly and Company